Latest filing published 19 Dec 2022 for Diagonal Bio AB, €9,140.
Insider track record
No signal scores available.
Edvard Hall: trading record in brief
This profile gathers the share dealings of Edvard Hall in Diagonal Bio AB. We count 2 filings, every one of them for a trade on 16 December 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 19 December 2022 came the latest disclosure, a transaction for €9,140 in Diagonal Bio AB. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Edvard Hall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 148,000 shares@ SEK 0.68100.0% of flowBTA (betald tecknad aktie)ISIN SE0019173832FI:csv-6cbfe3aaed53c229ff35
- 37,000 shares0Teckningsrätt/UniträttISIN SE0019173824FI:csv-3c6e0491265d555317c9
2 of 2 declarations